Our findings in type 1 diabetes support the prevailing hypothesis that small-fiber dysfunction occurs early in diabetic sensorimotor polyneuropathy. However, further research is required to determine which combination of small-fiber tests is most suitable as a surrogate marker in clinical trials (Diabetes Care)